Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
284
-
Total 13F shares, excl. options
-
66,741,578
-
Shares change
-
-1,808,335
-
Total reported value, excl. options
-
$5,067,062,425
-
Value change
-
-$136,060,448
-
Number of buys
-
137
-
Number of sells
-
-125
-
Price
-
$75.88
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2016
300 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2016.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 284 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66,741,578 shares
of 71,941,794 outstanding shares and own 92.77% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (8,960,969 shares), VANGUARD GROUP INC (5,714,731 shares), Neuberger Berman Group LLC (4,244,212 shares), FRANKLIN RESOURCES INC (3,963,144 shares), BlackRock Fund Advisors (2,590,242 shares), STATE STREET CORP (2,533,900 shares), BlackRock Institutional Trust Company, N.A. (2,298,236 shares), BAMCO INC /NY/ (2,274,371 shares), Select Equity Group, L.P. (2,013,425 shares), and ROYAL BANK OF CANADA (1,455,194 shares).
This table shows the top 284 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.